#MAFLD Archives - MediaMedic

AASLD 2024丨Dr. Jun Chen: Advances in Diagnosis and Prognosis of MAFLD

By Lisa Cui 2024.12.10

At the 75th Annual Meeting of the American Association for the Study of Liver Diseases (AASLD), metabolic-associated fatty liver disease (MAFLD) garnered significant attention. Dr. Jun Chen from Shenzhen Third People’s…

AASLD 2024丨Weight-Loss Surgery vs. Medication: A 5-Year Mortality Comparison in MAFLD Patients

By Peng Longmei 2024.12.04

The rising mortality rate among patients with metabolic dysfunction-associated fatty liver disease (MAFLD) underscores the need for effective interventions. At the 2024 AASLD Annual Meeting, Dr. Leith Ghani from the…

Metabolic-Related Diseases in Autoimmune Hepatitis Patients Promote Liver Fibrosis

By Peter W. PENG 2024.10.21

Introduction: Autoimmune hepatitis (AIH) is a chronic liver disease that affects both men and women, with about 30% of AIH cases occurring in individuals over 60 years old. Metabolic syndrome,…

Dr. Lai Wei: Interpretation of Key Points from the 2024 Edition of the Chinese Guidelines for the Prevention and Treatment of Metabolic (Non-Alcoholic

By Lisa Cui 2024.10.15

Editor's note: Liver diseases, primarily viral hepatitis, metabolic-associated fatty liver disease (MAFLD), and alcoholic liver disease, affect approximately 400 million people in China. With the increasing pace of life, unhealthy…

AASLD Voice of China | Dr. Chao Wu and Dr. Jie Li’s Team at Nanjing Drum Tower Hospital Focus on Non-invasive Diagnosis

By Lisa Cui 2024.01.18

Risk Factors, and Treatment Management of Hepatitis, Yielding Fruitful Results! Editor's Note: Hepatitis B virus (HBV) infection is a widespread global health issue. According to the World Health Organization, as…